Theriva Biologics and the Universitat Autònoma de Barcelona to receive a total of €2.28 Million to support the THERICEL project, a suspension cell platform for manufacturing viral-based therapies ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback